Abstracts
Article Nº AJ17-10
99MTC RH-ANNEXIN V FOR IMAGING APOPTOTIC CELLS: CLINICAL EXPERIENCE
LYMPHOSCINTIGRAPHY WITH 99MTC-DEXTRAN AND RADIOGUIDED BIOPSY IN SENTINEL NODE LOCALIZATION IN BREAST CANCER
99M TC -DEXTRAN LYMPHOSCINTIGRAPHY AND RADIO GUIDED BIOPSY FOR LOCALIZING THE SENTINEL NODE IN MALIGNANT MELANOMA
COMPARISON OF 99MTC-MIBI SCANNING AND SENTINEL NODE BIOPSY IN THE DETECTION OF OCCULT MELANOMA LYMPH NODE METASTASES
REGIONAL LYMPH NODE STAGING IN MELANOMA PATIENTS BY MEANS OF 99MTC-MIBI SCINTIGRAPHY
LYMPHATIC MAPPING AND SENTINEL NODE IDENTIFICATION IN PATIENTS WITH CERVIX CANCER UNDERGOING RADICAL HYSTERECTOMY
A VERY ACCURATE METHOD FOR SENTINEL LYMPH NODE INVESTIGATION: GAMMA DETECTING PROBE ASSICIATED WITH SPECT EXAMINATION FOR DEPTH
OCULAR MELANOMA IMAGING WITH 99M TC (V)DIMERCAPTO SUCCINIC ACID IN THYROTOXIC (GRAVE'S) PATIENTS PRETREATED WITH RADIOIODINE
[18F]FLUOROETANIDAZOLE FOR IMAGING MODULATED TUMOUR HYPOXIA WITH POSITRON EMISSION TOMOGRAPHY (PET)
PROGNOSTIC FACTORS FOR CARCINOMA OF UNKOWN PRIMARY LOCALIZED TO THE NECK ONLY (CUP SYNDROME) AND THE ROLE OF F-18-FDG PET FOR DIAGNOSIS AND THERAPEUTIC MANAGEMENT
CHOLECYSTOKININ(CCK)-B/GASTRIN-RECEPTOR BINDING PEPTIDES FOR DIAGNOSIS AND THERAPY OF METASTATIC MEDULLARY THYROID CANCER (MTC)
DOES EXTERNAL SCINTIGRAPHY ALLOW FOR PREDICTIONS WITH RESPECT TO THE TOXICITY AND THERAPEUTIC EFFICACY OF HERCEPTIN® THERAPY OF HER2/NEU EXPRESSING BREAST CANCER ?
COMPLEMENTARY ROLE OF 3'-DEOXY-3'-[F-18] FLUOROTHYMIDINE (FLT) AND F-18-FDG PET IMAGING IN ONCOLOGY
INFLUENCE OF THE DEPTH AND THE SITE OF THE NIDUS IN INTRAOPERATIVE LOCALISATION OF OSTEOID OSTEOMA
A COMPARATIVE STUDY OF 99MTC-HL91 AND 99MTC-MIBI IMAGING IN EXPERIMENTAL TUMOR AND INFLAMMATORY MODELS
USING 99TCM-MIBI MAMMOSCINTIGRAPHY TO DIFFERENTIATE NODULAR LESIONS OF BREAST AND DETECT AXILLARY LYMPH NODE METASTASES FROM BREAST CANCER
A SELF-CONTROL STUDY OF THREE RADIOPHARMACEUTICALS FOR LOCATING SENTINEL LYMPH NODE
LYMPHATIC MAPPING AND SENTINEL LYMPH NODE DETECTIONIN PATIENTS WITH BREAST CANCER
DETECTION OF THE CUTANEOUS MELANOMAS, THEIR METASTASIS AND RELAPSES BY SCINTIGRAPHIES WITH 99MTC-HMPAO.
ROLE OF TC-99M-METHOXYISOBUTYLISONITRILE SCINTIMAMMOGRAPHY COMPARED TO MAMMOGRAPHY IN THE DETECTION OF BREAST CANCER IN VENEZUELAN WOMEN
EVALUATION OF THE LYMPHATIC DRAINAGE OF THE THYROID TUMORS USING LYMPHOSCINTIGRAPHY
EFFICACY OF 18FDG PET STUDY IN DETECTION OF COLON CARCINOMA
QUANTITATIVE DYNAMIC PET FDG STUDIES FOR THE DIFFERENTIATION OF BONE LESIONS
PROGNOSTIC ASPECTS OF FDG PET IN PATIENTS WITH METASTATIC COLORECTAL CANCER
A. Dimitrakopoulou-Strauss
COMPARISON OF QUANTITATIVE PET AND CYCLIN-A EXPRESSION
COMPARISON BETWEEN NON-DEDICATED POSITRON EMISSION TOMOGRAPHY (NPET)WITH [F18] FLUOR DEOXI GLUCOSE (FDG)AND RADIONUCLIDE-LABELED SOMATOSTATIN ANALOGUES FOR THE DIAGNOSTIC PURPOSES IN THE DIFFERENTIAL THYROID CANCER
RETROSPECTIVE ANALYSIS OF SENSIBILITY AND IMPACT OF NON-DEDICATED POSITRON EMISSION TOMOGRAPHY (NPET) IN THE MANAGEMENT OF PATIENTS WITH CANCER
TO ASSESS THE DIAGNOSTIC ACCURACY OF 99M-TC-MIBI PLANAR & SPECT IMAGING IN DIFFERENTIATING SCAR TISSUE FROM RECURRENCE OF BREAST CARCINOMA AFTER SURGERY
EFFECTS OF TC-99M SULFUR COLLOID FILTRATION ON AXILLARY SENTINEL NODE VISUALIZATION DURING PREOPERATIVE BREAST LYMPHOSCINTIGRAPHY
COMBINING FUNCTIONAL CT AND FDG PET ALLOWS THE CALCULATION OF FDG EXTRACTION FRACTION AND HEPATIC GLUCOSE PHOSPHORYLATION
RADIO-GUIDED SURGERY IN VULVAR CANCER- FIRST EXPERIENCES
RADIO-GUIDED SURGERY IN CERVICAL CANCER- FIRST EXPERIENCES
FDG PET IN THE DIAGNOSIS OF MENINGEAL CARCINOMATOSIS
STANDARDIZED UPTAKE VALUE OF FDG CORRECTED BY LEAN BODY MASS MEASURED BY DEXA
MAMMOGRAPHY AND SCINTIMAMMOGRAPHY IN DIAGNOSIS OF BREAST CANCER
99TCM-HMPAO UPTAKE IN BREAST CANCER
EARLY ASSESSMENT OF NEOADJUVANT CHEMOTHERAPY BY FEC-COURSES OF LOCALLY ADVANCED BREAST CANCER USING 99TCM-MIBI (SESTAMIBI) AND SPECT
SENTINEL NODE LOCALIZATION IN BREAST CANCER: EVALUATION OF CONTROVERSIES
RADIOLABELLED PHAGE DISPLAY PEPTIDE DERIVATIVES INHIBITING MATRIX METALLOPROTEINASES TARGET XENOGRAFTED TUMORS IN MICE
DIAGNOSTIC UTILITY OF RADIONUCLIDE PERFUSION SCAN AND IMMUNOCYTOLOGY IN EVALUATION OF SOLITARY THYROID NODULES
IMAGING CELLULAR TARGETS IN ONCOLOGY
COMPARATIVE BREAST PHANTOM STUDIES OF TOMOGRAPHIC SCINTIMAMMOGRAPHY PERFORMED WITH PET AND SPECT
UNUSUAL CARDIOVASCULAR FINDINGS ON TOTAL-BODY F-18-FDG PET SCANS IN ONCOLOGY PATIENTS
ACQUIRING ADDITIONAL DELAYED PET IMAGES IMPROVES SENSITIVITY AND SPECIFICITY IN ONCOLOGY CASES
WHOLE-BODY FDG-POSITRON EMISSION TOMOGRAPHY IN BONE METASTASES. COMPARISON WITH BONE SCINTIGRAPHY.
EFFECT OF THE BREAST LESION SIZE AND PATIENT AGE ON OUTCOME OF RESULTS OF SCINTIMAMMOGRAPHY IN INDIAN WOMEN: A HEAD TO HEAD COMPARISON OF TC-99M TETROFOSMIN (TF) AND TC-99M METHYLENE DIPHOSPHONATE (MDP) SCINTIMAMMOGRAPHY (SMM)
DIAGNOSTIC VALUE OF EARLY 99M-TC METILENDIPHOSPHONATE SCINTIMAMMOGRAPHY IN THE ASSESSMENT OF PALPABLE BREAST TUMORS
DIAGNOSTIC VALUE OF 99M-TC GLUCOHEPTONATE SCINTIMAMMOGRAPHY IN THE ASSESSMENT OF PALPABLE BREAST TUMORS
SIGNIFICANCE OF THE SPEED OF LYMPHATIC DRAINAGE FOR METASTATIC SPREAD OF CUTANEOUS MALIGNANT MELANOMA
CARBON-11 ACETATE PET IN RECURRENT PROSTATE CANCER
LOCALISATION OF SENTINEL LYMPH NODES: WILL IT INFLUENCE THE MANAGEMENT OF PENIS CARCINOMA?
COMPARISON OF SUBDERMAL AND PERITUMORAL INJECTION TECHNIQUES OF LYMPHOSCINTIGRAPHY TO DETERMINE THE SENTINEL LYMPH NODE IN BREAST CANCER
99MTC SOMATOSTATING IMAGING FOR DETECTION OF SOMATOSTATING RECEPTOR.A PRELIMINARY RESULTS
DIAGNOSIS BRAIN TUMORS WITH TC-99M-MIBI AND FOLOW-UP SURROUNDING OEDEMA AFTER AND POST OEDEMA THERAPY WITH TC-99M-ECD
TECHNETIUM-99M LABELED ANTISENSE OLIGONUCLEOTIDE-NONINVASIVE TUMOR IMAGING IN MICE
EVALUATION OF TC-99M SESTAMIBI SCINTIMAMMOGRAPHY IN THE DIAGNOSIS OF BREAST CANCER PATIENTS
FEASIBILITY OF LYMPHOSCINTIGRAPHY OF THE GASTRIC CARDIA
MAPPING LYMPHATIC NODES: ROLE OF THROMBOSPONDIN
VEGF EXPRESSION AND FDG KINETICS
COMPARISON OF DYNAMIC FDG PET AND GENE CHIP DATA
FIVE YEAR EXPERIENCE IN THE DETECTION OF RECURRENCE OF OVARIAN CANCER WITH [F18]-FDG USING AN HYBRID (CDET) GAMMA CAMERA
PHASE I CLINICAL TRIAL OF THE HUMANIZED ANTI-EGF-R ANTIBODY H-R3 LABELED WITH 99MTC IN PATIENTS WITH TUMOR OF EPITHELIAL ORIGIN
INCREASED UPTAKE IN THE END OF LONG BONES ON BONE SCAN IN MULTIPLE MYELOMA
FEASIBILITY OF TC-99M BRU 59-21 IN ASSESSING TUMOR HYPOXIA IN HEAD AND NECK CANCER
REPRODUCIBILITY OF SENTINEL NODE LYMPHOSCINTIGRAPHY IN BREAST CANCER
NOVEL RADIOLABELLED PYRIMIDINE NUCLEOSIDE MIMICS FOR SCINTIGRAPHIC ASSESSMENT OF TISSUE PROLIFERATION
USING 99MTC-MIBI TO EVALUATE THE EFFECTS OF CHEMOSENSITIZER ON P-GLYCOPROTEIN IN MULTIDRUG-RESISTANT CARCINOMA CELLS
99MTC-HYNIC-TNF ANALOGUES (WH701) DERIVED FROM PHAGE DISPLAY PEPTIDE LIBRARIES FOR IMAGING TNF -RECEPTOR-POSITIVE OVARIAN CARCINOMA: PRECLINICAL EVALUATION
VALUE OF 18F-FDG POSITRON EMISSION TOMOGRAPHY IN CLINICAL STAGING AND FOLLOW-UP OF GASTRIC CARCINOMA
Cardiovascular |Cost Benefits|Endocrinology |Gastroenterology |Hematology |Infection| Musculoskeletal |Nephro-Urology |Neuro-Psychiatric Disorders |Oncology Diagnosis |Oncology Therapy |Pediatrics|Physics |Pulmonary |Radiopharmacy |Technology
Sitio desarrollado por SISIB - Universidad de Chile